Proteostasis

PTI NASDAQ
0.6573
-0.0114
-1.70%
After Hours: 0.6573 0 0.00% 16:00 08/20 EDT
Open
0.6695
Prev Close
0.6687
High
0.6810
Low
0.6558
Volume
301.07K
Avg Vol (3M)
956.87K
52 Week High
10.38
52 Week Low
0.6100
% Turnover
0.59%
Market Cap
33.61M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Proteostasis PTI stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. The Company focuses on identifying therapies that restore protein function. The Company’s CF focused pipeline consists of novel CFTR modulators including correctors, potentiators and amplifiers. The Company’s clinical developments include PTI-801, a third generation CFTR corrector, PTI-808, a CFTR potentiator, and PTI-428, a CFTR amplifier.
MORE >

Recently

Name
Price
%Change